Steven B. Maron

2.6k total citations
67 papers, 770 citations indexed

About

Steven B. Maron is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Steven B. Maron has authored 67 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 22 papers in Surgery. Recurrent topics in Steven B. Maron's work include Gastric Cancer Management and Outcomes (35 papers), Cancer Genomics and Diagnostics (19 papers) and Esophageal Cancer Research and Treatment (14 papers). Steven B. Maron is often cited by papers focused on Gastric Cancer Management and Outcomes (35 papers), Cancer Genomics and Diagnostics (19 papers) and Esophageal Cancer Research and Treatment (14 papers). Steven B. Maron collaborates with scholars based in United States, South Korea and Japan. Steven B. Maron's co-authors include Daniel V.T. Catenacci, Smita S. Joshi, Yelena Y. Janjigian, Samantha Lomnicki, Leah M. Chase, Rebecca J. Nagy, Richard B. Lanman, Jeeyun Lee, Seung Tae Kim and Lesli A. Kiedrowski and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Steven B. Maron

60 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven B. Maron United States	15	426	370	261	188	132	67	770
Futoshi Miyazono Japan	17	367 0.9×	386 1.0×	229 0.9×	140 0.7×	132 1.0×	33	827
Kit Curtius United States	15	194 0.5×	238 0.6×	251 1.0×	270 1.4×	40 0.3×	36	825
Ali H. Zaidi United States	21	296 0.7×	287 0.8×	585 2.2×	136 0.7×	250 1.9×	83	1.1k
Hideki Amemiya Japan	13	196 0.5×	277 0.7×	262 1.0×	90 0.5×	65 0.5×	17	676
Moon Soo Lee South Korea	15	198 0.5×	313 0.8×	133 0.5×	114 0.6×	34 0.3×	58	692
Naoshi Nishida Japan	11	164 0.4×	375 1.0×	217 0.8×	114 0.6×	42 0.3×	26	707
Gu Mi United States	14	240 0.6×	440 1.2×	179 0.7×	59 0.3×	59 0.4×	44	620
Luı́s Cirnes Portugal	16	210 0.5×	309 0.8×	194 0.7×	163 0.9×	28 0.2×	39	788
Saburo Nakashima Japan	13	281 0.7×	229 0.6×	234 0.9×	49 0.3×	85 0.6×	26	554
David Borg Sweden	12	177 0.4×	391 1.1×	164 0.6×	131 0.7×	32 0.2×	20	617

Countries citing papers authored by Steven B. Maron

Since Specialization

Citations

This map shows the geographic impact of Steven B. Maron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven B. Maron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven B. Maron more than expected).

Fields of papers citing papers by Steven B. Maron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven B. Maron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven B. Maron. The network helps show where Steven B. Maron may publish in the future.

Co-authorship network of co-authors of Steven B. Maron

This figure shows the co-authorship network connecting the top 25 collaborators of Steven B. Maron. A scholar is included among the top collaborators of Steven B. Maron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven B. Maron. Steven B. Maron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Artz, Oliver, Peter Ntiamoah, Caroline Weipert, et al.. (2025). Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 32(6). 1100–1109. 1 indexed citations

Maron, Steven B., Keisho Chìn, Fadi S. Braiteh, et al.. (2025). Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers. ESMO Open. 10(11). 105806–105806.

Maron, Steven B., Manish Sharma, Alexander I. Spira, et al.. (2025). Preclinical and phase 1/2 data of the CHK1 inhibitor BBI-355 in development for esophageal and gastric cancers (EGC) with EGFR or FGFR2 amplifications.. Journal of Clinical Oncology. 43(4_suppl). 1 indexed citations

Jayaprakasam, Vetri Sudar, Megan Tenet, Laura H. Tang, et al.. (2025). PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma. European Journal of Surgical Oncology. 51(5). 109589–109589.

Suman, Shalabh, Joanne F. Chou, Peter M. Krein, et al.. (2024). Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC).. Journal of Clinical Oncology. 42(16_suppl). 4041–4041. 3 indexed citations

Muro, Kei, Keisho Chìn, Steven B. Maron, et al.. (2024). Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202.. Journal of Clinical Oncology. 42(16_suppl). 4046–4046. 2 indexed citations

Gui, Chengcheng, Henry Walch, Ahmet Turan Ilıca, et al.. (2024). Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases. Journal of neurosurgery. 142(2). 1–11.

Tang, Laura H., Kanika Arora, Stephanie King, et al.. (2024). Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young‐ and Average‐Onset Gastric Cancer. Cancer Medicine. 13(23). e70451–e70451. 1 indexed citations

Pandit‐Taskar, Neeta, Melissa Lumish, Steven B. Maron, et al.. (2024). ¹⁸F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer. Journal of Nuclear Medicine. 65(5). 722–727. 7 indexed citations

10.

Huffman, Brandon M., Vasily N. Aushev, Joseph Chao, et al.. (2022). Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precision Oncology. 6(6). e2200420–e2200420. 36 indexed citations

11.

Lumish, Melissa, Steven B. Maron, Viktoriya Paroder, et al.. (2022). Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using⁸⁹Zr-Trastuzumab PET: A Pilot Study. Journal of Nuclear Medicine. 64(5). 724–730. 14 indexed citations

12.

Klemen, Nicholas D., Colin M. Court, Henry Walch, et al.. (2022). Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade. Annals of Surgical Oncology. 29(13). 8373–8382. 2 indexed citations

13.

Catenacci, Daniel V.T., Steven B. Maron, Benjamin Solomon, et al.. (2021). 960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC. Annals of Oncology. 32. S830–S831. 5 indexed citations

14.

Maron, Steven B., et al.. (2020). Targeting EGFR in Esophagogastric Cancer. Frontiers in Oncology. 10. 553876–553876. 15 indexed citations

15.

Maron, Steven B., Leah M. Chase, Samantha Lomnicki, et al.. (2019). Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma. Clinical Cancer Research. 25(23). 7098–7112. 147 indexed citations

16.

Uppal, Abhineet, Fabrice Smieliauskas, Steven B. Maron, et al.. (2019). Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer. 126(2). 281–292. 12 indexed citations

17.

Klempner, Samuel J., Russell W. Madison, Jeffrey S. Ross, et al.. (2019). FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape. The Oncologist. 24(11). 1462–1468. 17 indexed citations

18.

Maron, Steven B., Lindsay Alpert, Heewon Kwak, et al.. (2018). Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma. Cancer Discovery. 8(6). 696–713. 79 indexed citations

19.

Maron, Steven B. & Daniel V.T. Catenacci. (2017). Update on Gastroesophageal Adenocarcinoma Targeted Therapies. Hematology/Oncology Clinics of North America. 31(3). 511–527. 14 indexed citations

20.

Orsi, Renato H., et al.. (2008). Lineage specific recombination and positive selection in coding and intragenic regions contributed to evolution of the main Listeria monocytogenes virulence gene cluster. Infection Genetics and Evolution. 8(5). 566–576. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact